Market Cap 5.68M
Revenue (ttm) 0.00
Net Income (ttm) -69.63M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 327,000
Avg Vol 211,763
Day's Range N/A - N/A
Shares Out 841,000.00
Stochastic %K 23%
Beta 0.93
Analysts Strong Sell
Price Target $18.00

Company Profile

Jade Biosciences, Inc. operates as a biotechnology company that develops therapies for inflammation and immunology indications in patients living with autoimmune diseases. The company was incorporated in 2024 and is headquartered in Waltham, Massachusetts.

Industry: Biotechnology
Sector: Healthcare
Phone: 916 322 1700
Address:
221 Crescent Street Building 23, Suite 105, Waltham, United States
Plain360
Plain360 Jun. 17 at 12:46 AM
$JBIO Looks real good, currently oversold bigly.
0 · Reply
JarvisFlow
JarvisFlow Jun. 16 at 1:36 PM
Guggenheim has adjusted their stance on Jade Biosciences ( $JBIO ), setting the rating to Buy with a target price of 14.
0 · Reply
Aristoteli
Aristoteli Jun. 10 at 1:18 PM
$JBIO overpriced maybe will buy zone $3-$5
0 · Reply
mcrotary
mcrotary Jun. 10 at 10:01 AM
$JBIO added
0 · Reply
briefingcom
briefingcom Jun. 9 at 11:52 AM
Gapping Up: $JBIO +22.4% $MTSR +21.5% $NAMS +10.2% $EVEX +8.8% $LEGN +7.2%
0 · Reply
QuiverQuant
QuiverQuant Jun. 2 at 7:46 PM
Jade Biosciences Announces Presentation of Preclinical Data on JADE101 at 62nd European Renal Association Congress. Read more about $JBIO: https://www.quiverquant.com/news/Jade+Biosciences+Announces+Presentation+of+Preclinical+Data+on+JADE101+at+62nd+European+Renal+Association+Congress
0 · Reply
wesfabian1
wesfabian1 May. 19 at 6:58 PM
$JBIO has anyone heard of issues with the special dividend paid before the avte buyout? I heard firms like sofi did not pay and fidelity did for stocks purchased and sold on the same dates. A very confusing mess as the special dividend was greater than 25% of stock value and therefore was subject to special rules, but when one firm pays and another doesn't...
0 · Reply
Ghoku
Ghoku May. 15 at 6:12 AM
$JBIO The company has a $300 million cash runway through 2027, and JADE101 is expected to enter first-in-human trials in the second half of 2025. This stock will soar anytime soon.
0 · Reply
Ghoku
Ghoku May. 12 at 8:47 PM
$JBIO Hopefully we will get some good news from this week!
0 · Reply
Armonica423
Armonica423 May. 10 at 5:36 PM
$JBIO Big exposure for CYDY at 3 oncology conferences this coming week, do your dd research
0 · Reply
Plain360
Plain360 Jun. 17 at 12:46 AM
$JBIO Looks real good, currently oversold bigly.
0 · Reply
JarvisFlow
JarvisFlow Jun. 16 at 1:36 PM
Guggenheim has adjusted their stance on Jade Biosciences ( $JBIO ), setting the rating to Buy with a target price of 14.
0 · Reply
Aristoteli
Aristoteli Jun. 10 at 1:18 PM
$JBIO overpriced maybe will buy zone $3-$5
0 · Reply
mcrotary
mcrotary Jun. 10 at 10:01 AM
$JBIO added
0 · Reply
briefingcom
briefingcom Jun. 9 at 11:52 AM
Gapping Up: $JBIO +22.4% $MTSR +21.5% $NAMS +10.2% $EVEX +8.8% $LEGN +7.2%
0 · Reply
QuiverQuant
QuiverQuant Jun. 2 at 7:46 PM
Jade Biosciences Announces Presentation of Preclinical Data on JADE101 at 62nd European Renal Association Congress. Read more about $JBIO: https://www.quiverquant.com/news/Jade+Biosciences+Announces+Presentation+of+Preclinical+Data+on+JADE101+at+62nd+European+Renal+Association+Congress
0 · Reply
wesfabian1
wesfabian1 May. 19 at 6:58 PM
$JBIO has anyone heard of issues with the special dividend paid before the avte buyout? I heard firms like sofi did not pay and fidelity did for stocks purchased and sold on the same dates. A very confusing mess as the special dividend was greater than 25% of stock value and therefore was subject to special rules, but when one firm pays and another doesn't...
0 · Reply
Ghoku
Ghoku May. 15 at 6:12 AM
$JBIO The company has a $300 million cash runway through 2027, and JADE101 is expected to enter first-in-human trials in the second half of 2025. This stock will soar anytime soon.
0 · Reply
Ghoku
Ghoku May. 12 at 8:47 PM
$JBIO Hopefully we will get some good news from this week!
0 · Reply
Armonica423
Armonica423 May. 10 at 5:36 PM
$JBIO Big exposure for CYDY at 3 oncology conferences this coming week, do your dd research
0 · Reply
WallStreetBullDC
WallStreetBullDC May. 9 at 2:18 PM
$JBIO you all notice it at $5 then back at 9$ robinhood glitch?
0 · Reply
Spc_baller
Spc_baller May. 9 at 12:57 PM
$JBIO good time to enter?
0 · Reply
BlakeCanyon50
BlakeCanyon50 May. 9 at 12:37 PM
$JBIO Geez Louise..
0 · Reply
Ghoku
Ghoku May. 9 at 11:41 AM
0 · Reply
WallStreetBullDC
WallStreetBullDC May. 9 at 10:39 AM
$JBIO 50% of value wiped in one go this morning 🤣 what are these jokers doing.
0 · Reply
NasdaqTurkeyGroup
NasdaqTurkeyGroup May. 8 at 8:39 PM
$JBIO added watch list ✅
0 · Reply
JarvisFlow
JarvisFlow May. 7 at 3:48 PM
Wedbush has adjusted their stance on Jade Biosciences ( $JBIO ), setting the rating to Outperform with a target price of 17.
1 · Reply
MrDaniels
MrDaniels May. 7 at 1:37 PM
$JBIO solid!!
0 · Reply
Spacerobot
Spacerobot May. 7 at 12:12 AM
$JBIO I didn't ride this joker through the rename, but it stinks to me.
0 · Reply
MrDaniels
MrDaniels May. 6 at 5:23 PM
$JBIO to TOPW! 💯🔥
0 · Reply
AnnaKan
AnnaKan May. 2 at 6:16 PM
$JBIO & $KIDZ doing great for the day so far !
0 · Reply
AnnaKan
AnnaKan May. 2 at 4:12 PM
$JBIO $SOPA doing well .. $DRCT $KIDZ will rebound higher ! GL 💚
0 · Reply